Stanford Study Shows Americans Inhaling Unintended Substances

Jun.02.2022
Stanford Study Shows Americans Inhaling Unintended Substances
A new study from Stanford University reveals that Americans are vaping non-nicotine substances, which can harm the lungs.

According to a report by FUTURITY website, a new study conducted by Stanford University reveals that Americans are consuming substances they never thought of inhaling before, including melatonin, essential oils, tea, vitamins, caffeine, and other non-nicotine substances.

 

This survey questioned the usage habits of over 6,000 adolescents, young adults, and adults aged 13-40. It is the first nationwide sample survey on the intake of non-nicotine products.

 

Scientists say that while some non-nicotine substances may be safe for ingestion, inhaling them through vaporization may harm the lungs. Chemicals, solvents, and flavors found in non-nicotine vaping products also exist in nicotine vaping products and have been shown to have harmful effects unrelated to nicotine.

 

According to Bonnie Halpern-Felsher, a professor of pediatrics at Stanford University School of Medicine and a senior author of a paper on the online edition of the Journal of the American Medical Association, "Our most striking finding was that nearly 14% of youths and 24% of young adults had used non-nicotine electronic cigarettes.

 

Non-nicotine electronic cigarettes currently evade regulation by the Food and Drug Administration for nicotine e-cigarettes or intake supplements, which means there are no restrictions on the equipment, ingredients, or marketing of these products. Additionally, there is no age limit for purchasing these products. According to Halpern-Felsher, many sellers make unfounded health claims, making electronic cigarettes appear safe to both youth and adults, despite their safety never being tested.

 

According to Halpern-Felsher, "Anything that is purchased, heated, and inhaled without a prescription is harmful to your lungs.

 

Investigation reveals

 

Researchers surveyed teenagers, young adults, and adults living across the United States, focusing on four age groups: 13-17, 18-20, 21-24, and 25-40. These groups represent different stages of development: early adolescence, young adulthood below the legal age for nicotine e-cigarette sales, prefrontal brain maturation during young adulthood, and adulthood. Participants' gender, race, and ethnicity were representative of the US population.

 

Participants answered questions about their use of non-nicotine electronic cigarettes, nicotine-containing electronic cigarettes, and combustible cigarettes. The survey asked if participants had ever used these products, if they had used them recently, and the timing of their first use of each product. The survey also included questions about usage patterns, specific brands, preferred flavors, and ingredients used in non-nicotine vaping devices.

 

Overall, approximately 26% of participants reported trying non-nicotine e-cigarettes, with nearly 17% reporting use within the past 30 days and approximately 12% within the past 7 days. Usage varied according to age, with the 21-24 year old group reporting the highest proportion of non-nicotine use (approximately 38%), followed by the 25-40 year old group at nearly 33%.

 

Approximately 14% of 13 to 17-year-olds and 24% of 18 to 20-year-olds have reported trying non-nicotine electronic cigarettes, with more than half of those individuals using these devices multiple times. On average, participants reported trying non-nicotine e-cigarettes at a younger age than nicotine e-cigarettes, raising concerns that non-nicotine devices could be a pathway to using nicotine-containing products.

 

What substances are people inhaling?

 

Many young survey participants are unaware of what they are vaping. Approximately 24% of teenagers aged 13 to 17 and 19% of young adults aged 18 to 20 reported that they do not know what is in the non-nicotine e-cigarettes they use.

 

Popular substances for consumption among teenagers and young people include tetrahydrocannabinol (THC), an active compound found in marijuana. Other substances include melatonin, cannabidiol (CBD), a non-psychoactive derivative of marijuana, essential oils, caffeine, and tea.

 

Among adults aged 25-40, caffeine, vitamin B, tea, and tetrahydrocannabinol are all popular. A complete list of substances found in non-nicotine electronic cigarettes includes vitamin C, lavender, essential oils, propylene glycol, glycerin, and other flavorings.

 

Halpern-Felsher stated that while the use of marijuana compounds isn't surprising, the popularity of other substances is unexpected and concerning.

 

The Food and Drug Administration has designated certain chemicals added to food, including vitamins and some flavorings, as "generally recognized as safe." However, this is not always the case.

 

According to Halpern-Felsher, the designation of GRAS (an indicator used by the US FDA to evaluate safety of food additives) means that certain things are safe to consume or use as a skin cream. However, there is a significant difference when it comes to inhaling aerosols produced by heating substances. This is where it affects your lungs.

 

Halpern-Felsher emphasized that the safety and potential risks or side effects of inhaling these substances are still not clear. Furthermore, non-nicotine e-cigarettes share common ingredients with nicotine-containing e-cigarettes, such as propylene glycol, glycerin, and flavoring compounds, all of which are known to be harmful to the lungs.

 

Unknown dangers

 

Halpern-Felsher has stated that for several common substances that are smoked, our existing knowledge of their chemical properties indicates that they pose harm to the lungs, and consumers should remain cautious.

 

She said, 'We really need toxicologists and other scientists to help us understand the impact of these chemicals on our bodies and by what mechanisms.' For example, she noted that excessive amounts of vitamins can have toxic effects. Pulmonary surfactants are oily substances produced by the body to lubricate lung air sacs. Inhaling evaporated fatty substances, such as essential oils, glycerin (a common ingredient in all e-cigarettes), and aromatic compounds, may interfere with lung function.

 

The message for everyone, especially young people, is that any inhaled aerosol, except for medication prescribed by a doctor (such as asthma treatment), could potentially be dangerous.

 

Halpern-Felsher stated, "Maintaining the health of our lungs has never been as critical as it is now during the COVID-19 pandemic.

 

She hopes that these findings will stimulate policy changes to better regulate the electronic cigarette industry, especially in terms of protecting youth.

 

We cannot allow non-nicotine products to be available for purchase in the open market anymore, especially considering the fact that young people are sharing and inhaling them without knowing what substances they contain. We need regulation and labelling measures to ensure that these products do not end up in the hands of young people.

 

Source: FUTURITY.

 


Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
Germany Probes 7.6 Million Illegal Vape Case With Estimated €33.3 Million Tax Loss; Four Chinese Manufacturer Employees Under Investigation, Some Packaging in Enforcement Images Resembles FUMOT Products
German prosecutors and customs authorities are conducting a criminal investigation into an alleged cross-border organised vape network. Authorities say that between January 2024 and March 2025, four employees of an unnamed Chinese e-cigarette manufacturer allegedly built a network of sales agents and wholesalers that brought more than 7.6 million nicotine disposable vapes into Germany, causing an estimated €33.3 million in excise-tax losses. The manufacturer has not been named. Some products visible in enforcement images have packaging resembling products from FUMOT’s portfolio. European regulatory records from 2024, FUMOT’s public overseas-sales materials and records involving German vape importer and distribution company Zamu-Pro GmbH also show FUMOT/RandM products and German distribution activity during the period covered by the investigation.
Sep.21
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Product | Philip Morris Japan Teams Up With Renowned French Audio Brand DEVIALET for Limited-Edition IQOS Priced 60% Above Standard Model
Philip Morris Japan (PMJ) launched the limited-edition IQOS ILUMA i PRIME Soundsorial Model in collaboration with French audio brand DEVIALET on October 1, 2026. Featuring sound-wave patterns, a silver-and-black finish and a gradient holder, the heated tobacco device is priced at JPY 15,980, including tax, and is available at four IQOS stores in Japan. According to Japanese media citing a PMJ representative, about 1,900 units were allocated to the Japanese retail market. A separate Soundsorial Collection, combining the device with DEVIALET Gemini II earbuds, includes 440 sets allocated to Japan for a membership prize draw.
product
Oct.23